- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
GemPharmatech Co Ltd (688046)
Assess today's live GemPharmatech Co Ltd (688046) share price, performance and insights using our live Shanghai: 688046 stock exchange data.
Analyse the historical data and GemPharmatech Co Ltd share price performance charts on this page. Our technical summary section provides analysis on GemPharmatech share price buy/sell indicators using real-time data (or discuss the GemPharmatech (688046) stock price today with other investors in the GemPharmatech SS share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current SS 688046 share price (ISIN: CNE100005964) to enhance your trading decisions with our free investment tools and resources.
What Is the GemPharmatech Co Ltd Share Price Today?
The GemPharmatech share price today is 20.28.
What Is the Stock Symbol for GemPharmatech Co Ltd
The stock symbol (or 'ticker') for GemPharmatech Co Ltd is "688046."
What Stock Exchange Does GemPharmatech Co Ltd Trade On?
GemPharmatech Co Ltd is listed and trades on the Shanghai stock exchange.
Is GemPharmatech Co Ltd a Good Stock to Buy?
Determining whether GemPharmatech Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and GemPharmatech Co Ltd share price performance charts on this page. Our technical summary section provides analysis on GemPharmatech share price buy/sell indicators using real-time data (or discuss the GemPharmatech (688046) stock price today with other investors in the GemPharmatech SS share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current SS 688046 share price (ISIN: CNE100005964) to enhance your trading decisions with our free investment tools and resources.
What Is the GemPharmatech Co Ltd Share Price Today?
The GemPharmatech share price today is 20.28.
What Is the Stock Symbol for GemPharmatech Co Ltd
The stock symbol (or 'ticker') for GemPharmatech Co Ltd is "688046."
What Stock Exchange Does GemPharmatech Co Ltd Trade On?
GemPharmatech Co Ltd is listed and trades on the Shanghai stock exchange.
Is GemPharmatech Co Ltd a Good Stock to Buy?
Determining whether GemPharmatech Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Shanghai
Currency in CNY
20.26
-0.27(-1.32%)
Delayed Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
19.89
20.70
52 wk Range
11.60
21.99
688046 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
19.8920.70
52 wk Range
11.6021.99
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.69%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.69%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
688046 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Strong Buy
Price Target
27.96
Upside
+38.01%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to grow this year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 27.96
(+38.01% Upside)
Earnings
Latest Release
23/04/2026
EPS / Forecast
-- / --
Revenue / Forecast
208M / --
Compare 688046 to Peers and Sector
Metrics to compare | 688046 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship688046PeersSector | |
|---|---|---|---|---|
P/E Ratio | 52.6x | 39.4x | −0.5x | |
PEG Ratio | 1.09 | 0.27 | 0.00 | |
Price/Book | 3.7x | 3.1x | 2.6x | |
Price / LTM Sales | 10.1x | 4.8x | 3.1x | |
Upside (Analyst Target) | 36.2% | 34.1% | 54.9% | |
Fair Value Upside | Unlock | 10.3% | 7.1% | Unlock |
GemPharmatech Co., Ltd., a contract research organization, provides genetically engineered mouse models and preclinical research services to the scientific community worldwide. The company offers mouse models, including knockout and conditional knockout mouse, disease mouse, immunodeficient mouse, germ-free mouse, and tool mice models, as well as operates wild mouse project. It also provides custom model generation, preclinical testing, germ-free and microbiome, cell lines and customization, custom breeding, animal quality testing, and other services. The company has a strategic alliance with Memorial Sloan Kettering Cancer Center (MSK) to accelerate the discovery of new therapeutic antibodies. The company was founded in 2017 and is headquartered in Nanjing, China.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the GemPharmatech (Shanghai: 688046) Share Price Today?
The GemPharmatech stock price today is 20.26 CNY.
What Stock Exchange Does GemPharmatech (688046) Trade On?
GemPharmatech is listed and trades on the Shanghai Stock Exchange.
What Is the Ticker (Stock Symbol) for GemPharmatech?
The stock symbol (also called a 'ticker') for GemPharmatech is "688046."
Does GemPharmatech Pay Dividends? What’s The Current 688046 Dividend Yield?
Yes, 688046 Pays Dividends to its Shareholders. The current GemPharmatech dividend yield is 0.69%.
What Is the Current GemPharmatech Market Capitalisation?
As of today, GemPharmatech (Shanghai: 688046) market cap is 8.40B CNY.
What Is GemPharmatech's (688046) Earnings Per Share (TTM)?
The GemPharmatech EPS is currently 0.40 (Trailing Twelve Months).
When Is the Next GemPharmatech Earnings Date?
GemPharmatech's next earnings report will be released on 17/08/2026.
Is 688046 a Buy or Sell From a Technical Analyst Perspective?
Based on today's GemPharmatech moving averages and other technical indicators, the daily buy/sell signal for 688046 stock is Sell.
How Many Times Has GemPharmatech Stock Split?
GemPharmatech has split 0 times. (See the 688046 stock split history page for full effective split date and price information.)
How Many Employees Does GemPharmatech Have?
GemPharmatech has 1590 employees, based on their latest Companies House report.
What is the current trading status of GemPharmatech (Shanghai: 688046)?
As of 28/05/2026, GemPharmatech (688046) is trading at a share price of 20.26 CNY, with a previous close of 20.53 CNY. The stock has fluctuated within a day range of 19.89 CNY to 20.70 CNY, while its 52-week range spans from 11.60 CNY to 21.99 CNY.
What Is GemPharmatech (688046) Price Target According to Analysts?
The average 12-month price target for GemPharmatech is 27.96 CNY, with a high estimate of 27.96 CNY and a low estimate of 27.96 CNY. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +38.01% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.